Lipum makes a share issue for faster progress

January 17th, 2019|

Being a European Commission Horizon 2020 beneficiary has a distinct positive impact on our development. The 2.2 M€ grant enables us to proceed faster towards a new drug against chronic inflammatory diseases. To further increase [...]

BIO-Europe in Copenhagen, Nov 5-7 2018

September 30th, 2018|

Lipum offer a new route for treatment of chronic inflammatory diseases. Meet with our CEO Einar Pontén and our CMC Project Manager Mats Reslow at BIO-Europe 2018 in Copenhagen, Nov 5-7. We will tell you more [...]

Lipum receives 2.2 M€ grant from Horizon 2020

August 29th, 2018|

Lipum's unique approach for treatment of chronic inflammatory diseases receives 2.2 M€ support from EU Horizon 2020, the EU framework program for research and development, will grant 2.2 million euros to Lipum’s ongoing development of [...]

Lipum company presentation at Biostock live

August 15th, 2018|

Lipum and some listed nordic life science companies will make company presentations in Stockholm at Nyhetsbyrån Direkt on August 29, 2018. The event is organised by Biostock and will also be broadcasted with start at [...]

Lipum selected as finalist at NLSDays

July 20th, 2018|

An international panel of life science investors have selected Lipum as one of 12 companies for the final of the live pitch competition at the Nordic Life Science Days 2018. Learn more about Lipum and [...]

Lipum received grant from SWElife

June 15th, 2018|

Our project "Validation of a biological candidate drug" has been granted support from SWElife "Projects for better health" program. The competition was fierce so the green tie was used during the interview and Lipum was [...]